BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3539066)

  • 1. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic hemagglutination inhibition test in examining of the culture supernatants of Clostridium botulinum types A, B, E, and F and some related bacterial species.
    Reiss J; Wojtyła B; Lipko A
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):531-9. PubMed ID: 6200089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insoluble antigens in the identification of Cl. botulinum. II. Agglutination and hemagglutination studies and complement fixation reaction].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):47-64. PubMed ID: 4132768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problem of non-soluble antigens in the identification of Cl. botulinum. I. Precipitation and immunofluorescence studies].
    Cygan Z
    Pol Arch Weter; 1972; 15(2):245-64. PubMed ID: 4572437
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of the passive hemagglutination inhibition reaction for the purpose of determining the antigenic activity of anatoxins in vitro].
    Vorontsov IV; Moshiashvili IIa; Severtsova MK; Besova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):62-6. PubMed ID: 375637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the serodiagnostic reactions of the bacterium Clostridium butyricum strain CNRZ 528 using passive hemagglutination].
    Prösch S; Benedix A
    Allerg Immunol (Leipz); 1982; 28(4):260-71. PubMed ID: 6219561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of soluble antigens by the reverse passive haemagglutination assay.
    Radu I; Mihalache D
    Roum Arch Microbiol Immunol; 1992; 51(4):205-11. PubMed ID: 1304825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insoluble antigens in the identification of Cl. botulinum. 3. Chemical studies of polysaccharides].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):65-83. PubMed ID: 4596012
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of Clostridium boltulinum toxins using passive hemagglutination].
    Franke F
    Zentralbl Veterinarmed B; 1974 Sep; 21(9):660-76. PubMed ID: 4619737
    [No Abstract]   [Full Text] [Related]  

  • 16. [A simplified method of rapid hemagglutination test for determining the levels of tetanus antibodies].
    Reiss J; Zawistowska-Marciniak I; Grzybowski J
    Med Dosw Mikrobiol; 1991; 43(1-2):51-4. PubMed ID: 1784138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on receptor specific proteins. II. Haemagglutination and haemagglutination-inhibition reactions of Clostridium botulinum types A, C, D and E haemagglutinins.
    Balding P; Gold ER; Boroff DA; Roberts TA
    Immunology; 1973 Nov; 25(5):773-82. PubMed ID: 4586739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Passive hemagglutination reaction in differentiating foot-and-mouth disease viruses].
    Tekerlekov P; Veleva E
    Vet Med Nauki; 1983; 20(3-4):7-13. PubMed ID: 6312672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect (passive) haemagglutination test for assay of antigen and antibody (a review).
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Acta Microbiol Hung; 1991; 38(2):81-90. PubMed ID: 1805503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.